New Statement Released by the FH Foundation on Genetic Testing for Familial Hypercholesterolemia

According to a story from the FH Foundation, the non-profit organization has released a vital consensus statement regarding the diagnosis of familial hypercholesterolemia, which is the most prevalent genetic cause…

Continue Reading New Statement Released by the FH Foundation on Genetic Testing for Familial Hypercholesterolemia
A Man With Spinal Muscular Atrophy is Stuck Without Access to Costly Treatment
https://pixabay.com/en/clock-time-watch-hours-minutes-407101/

A Man With Spinal Muscular Atrophy is Stuck Without Access to Costly Treatment

According to a story from cbc.ca, Cole Pringle is a 31-year-old man from Regina, Saskatchewan with spinal muscular atrophy, a debilitating illness that severely affects his mobility. He was diagnosed…

Continue Reading A Man With Spinal Muscular Atrophy is Stuck Without Access to Costly Treatment
Important Protein Complex That Allows Certain Cancer Drugs to be Effective is Discovered
geralt / Pixabay

Important Protein Complex That Allows Certain Cancer Drugs to be Effective is Discovered

According to a story from rdmag.com, researchers from the University of Toronto have discovered a critical mechanism that helps facilitate the normal DNA repair process. This mechanism could have implications…

Continue Reading Important Protein Complex That Allows Certain Cancer Drugs to be Effective is Discovered
New Treatment for Pheochromocytoma and Paraganglioma Approved by the FDA
valelopardo / Pixabay

New Treatment for Pheochromocytoma and Paraganglioma Approved by the FDA

According to a story from globenewswire.com, the company Progenic Pharmaceuticals recently reported the the U.S. Food and Drug Administration has recently approved the company's product iobenguane I 131 (AZEDRA). This…

Continue Reading New Treatment for Pheochromocytoma and Paraganglioma Approved by the FDA
The FDA Have Awarded Orphan Drug Designation to an Experimental Treatment for Dermatomyositis
Aymanjed / Pixabay

The FDA Have Awarded Orphan Drug Designation to an Experimental Treatment for Dermatomyositis

The US Food and Drug Administration has awarded Orphan Drug Designation to the drug lenabasum as a treatment for dermatomyositis. The use of lenabasum for treating this condition, and others,…

Continue Reading The FDA Have Awarded Orphan Drug Designation to an Experimental Treatment for Dermatomyositis

A Long Term Study of a Treatment for Autosomal Dominant Polycystic Kidney Disease Has Finished

According to a story from Medical Xpress, a long term study testing a treatment for autosomal dominant polycystic kidney disease (ADPKD) has recently concluded. The treatment in question is a…

Continue Reading A Long Term Study of a Treatment for Autosomal Dominant Polycystic Kidney Disease Has Finished
For Children With Debilitating Illness, the Wait for Medical Equipment Can be Agonizing
klimkin / Pixabay

For Children With Debilitating Illness, the Wait for Medical Equipment Can be Agonizing

According to a story from the Los Angeles Daily News, for children with debilitating rare illnesses like cerebral palsy, epilepsy, or muscular dystrophy, it can often take a long time…

Continue Reading For Children With Debilitating Illness, the Wait for Medical Equipment Can be Agonizing
Chemo Can Save Lives, But More Approaches Are Needed To Handle Its After Effects
biker_becca / Pixabay

Chemo Can Save Lives, But More Approaches Are Needed To Handle Its After Effects

According to a story from healthline.com, many cancer survivors that have been treated with chemotherapy wind up facing significant challenges after their treatment. One such example is a phenomenon known…

Continue Reading Chemo Can Save Lives, But More Approaches Are Needed To Handle Its After Effects
Mantle Cell Lymphoma Patients in Western Australia Will Get Much Cheaper Access to Essential Treatment
PixelAnarchy / Pixabay

Mantle Cell Lymphoma Patients in Western Australia Will Get Much Cheaper Access to Essential Treatment

According to a story from news.com.au, patients in Western Australia will start getting much cheaper access to a highly valuable treatment next month for a rare form of cancer called…

Continue Reading Mantle Cell Lymphoma Patients in Western Australia Will Get Much Cheaper Access to Essential Treatment
The FDA Have Approved Xtandi® as a Treatment for Non-Metastatic Castration-Resistant Prostate Cancer
Source: Pixabay.com

The FDA Have Approved Xtandi® as a Treatment for Non-Metastatic Castration-Resistant Prostate Cancer

A drug to treat prostate cancer has been approved by the US Food and Drug Administration. The drug, Xtandi ® (enzalutamide), had previously been approved for castration-resistant prostate cancer (CRPC)…

Continue Reading The FDA Have Approved Xtandi® as a Treatment for Non-Metastatic Castration-Resistant Prostate Cancer